The identification of ADORA1 as a key target for T2DM and related complications (e.g., nephropathy) therapy buttresses previous studies (on morusin, kuwanon C, and morusyunnansin) from Morus alba (leaves) and Salvia miltiorhiza through NP and molecular docking analyses [77,78]. This evidence concerns the gene ADORA1 and kidney disorder.